A retired judge ordered more than $35.6 million paid back to Paulson and concluded he was justified in firing one of his top executives.

The Iraq national men's team hasn't played a World Cup in 40 years; a drought that ends Tuesday night, to the excitement of soccer fans in Dearborn, Michigan, home to a large Iraqi diaspora.

The Dan David Prize will award nine historians and archaeologists with $300,000 to recognize their work and support future research, the foundation announced Tuesday.

Waymo has tapped fleet management company Element to help keep its robotaxis charged, maintained, and on the road as the company expands into more cities.

Bill Simmons believes Jalen Brunson’s championship run has changed the way he should be viewed historically.

New York Governor Kathy Hochul announced that nearly 3 million homeowners in New York will receive over $2 billion in refunds through the annual STAR program, which helps families and older New Yorkers afford to live in the state.

As Vance entered the Disney-owned network's Lower Manhattan studio to discuss his new book, “Communion,” the show’s cohosts rose to welcome him.

An Ariane 6 heavy-lift rocket will launch a record-breaking load to orbit early on Wednesday morning (June 17), and you can watch the action live.

Using an innovative combination of biochemical experiments and ultra-high-resolution microscopy, a research team at Kiel University has solved the long-standing mystery of how the bacterium B. subtilis regulates its cell division.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become popular for weight loss, but results vary from person to person and from drug to drug. Venky Soundararajan and colleagues explored the full range of responses to tirzepatide (e.g., Mounjaro or Zepbound) and semaglutide (e.g., Ozempic, Wegovy or Rybelsus) by analyzing de-identified electronic health records for matched cohorts of 10,339 tirzepatide-treated and 10,339 semaglutide-treated patients. In the real world, outcomes ranged from minimal weight loss to more than a 25% reduction in body weight.

A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also help kidney tissue repair and regenerate, researchers have found.